Yahoo
NasdaqCM - Delayed Quote USD

SAB Biotherapeutics, Inc. (SABSW)

0.0011 -0.0032 (-74.42%)
At close: October 22 at 3:59:37 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-53,937.1110
-44,775.1110
-34,292.0090
-25,119.4050
-23,459.5110
Investing Cash Flow
-202,106.1300
-121,706.1300
-11,962.2670
-152.7040
-2,090.0240
Financing Cash Flow
260,932.4520
168,299.4520
-1,172.6260
66,773.1370
1,051.4110
End Cash Position
8,580.2110
10,502.6800
8,897.9660
56,566.0660
15,046.8940
Interest Paid Supplemental Data
232.0320
242.0320
373.9540
245.4810
293.3920
Capital Expenditure
--
-933.1560
-337.2620
-197.1540
-2,166.4140
Issuance of Capital Stock
257,426.8270
168,729.8270
0
7,500
7,680.7990
Issuance of Debt
--
0
515.9860
765.1940
1,236.1250
Repayment of Debt
-148.4120
-418.4120
-1,422.9850
-1,155.6390
-2,421.2380
Repurchase of Capital Stock
--
--
--
0
-5,521.2460
Free Cash Flow
-57,439.2670
-45,708.2670
-34,629.2710
-25,316.5590
-25,625.9250
12/31/2022 - 7/17/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: